Merck, Inc.
🇺🇸United States
Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)
Phase 2
Completed
- Conditions
- Cough
- First Posted Date
- 2005-09-30
- Last Posted Date
- 2015-09-16
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 91
- Registration Number
- NCT00230230
Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)
Completed
- Conditions
- Infection, Invasive Fungal
- First Posted Date
- 2005-09-30
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 330
- Registration Number
- NCT00230243
Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
Phase 3
Completed
- Conditions
- Foot Infections in Diabetic Patients
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 400
- Registration Number
- NCT00229112
Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C
Phase 1
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT00227435
Instrument Utility for Suspected Asthma (0000-042)(COMPLETED)
Not Applicable
Completed
- Conditions
- Asthma
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-01-05
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 400
- Registration Number
- NCT00211575
A Study in Subjects With Perennial Allergic Rhinitis
Phase 2
Completed
- Conditions
- Perennial Allergic Rhinitis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2016-01-25
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 630
- Registration Number
- NCT00210015
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 12
- Registration Number
- NCT00210093
A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)
Phase 3
Completed
- Conditions
- Lung Cancer
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 700
- Registration Number
- NCT00210080
A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
Phase 2
Completed
- Conditions
- Psychotic DisordersDepressionDepressive Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 273
- Registration Number
- NCT00212797
A Pharmacokinetic Evaluation Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 4
- Registration Number
- NCT00210054
© Copyright 2025. All Rights Reserved by MedPath